Home/Filings/4/0001485003-16-000111
4//SEC Filing

Eleven Biotherapeutics, Inc. 4

Accession 0001485003-16-000111

$CARMCIK 0001485003operating

Filed

Jun 16, 8:00 PM ET

Accepted

Jun 17, 4:14 PM ET

Size

5.6 KB

Accession

0001485003-16-000111

Insider Transaction Report

Form 4
Period: 2016-06-15
MCCABE JOHN J
Senior Vice President, Finance
Transactions
  • Award

    Stock Option (Right to Buy)

    2016-06-15+6,6726,672 total
    Exercise: $0.28From: 2016-06-15Exp: 2026-02-24Common Stock (6,672 underlying)
Footnotes (1)
  • [F1]On February 25, 2016, the reporting person was granted an option to purchase 20,000 shares of common stock. This option vests in installments based on the achievement of certain regulatory and business milestones. The Compensation Committee of the Company determined that one of these performance milestones was met, resulting in vesting of the option with respect to 6,672 shares.

Issuer

Eleven Biotherapeutics, Inc.

CIK 0001485003

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001485003

Filing Metadata

Form type
4
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 4:14 PM ET
Size
5.6 KB